Regulatory T cells & parasites: therapeutic potential

Slides:



Advertisements
Similar presentations
José Pedro Lopes Exhausted CD3 CD8 TCR TIM3 1B11 LAG3 Generated in chronic antigen- mediated TCR stimulation. Express inhibitory receptors and lack effector.
Advertisements

Manipulation of the Immune Response Chapter 14
Parasite Therapy The Mechanisms Behind the Hygiene Hypothesis.
Introduction to Autoimmunity Alon Monsonego, Ph.D. The department of Microbiology and Immunology Tel:
Musketeers Course October The Mucosal Immune System The organization of the mucosal immune systemThe organization of the mucosal immune system The.
Contact Information: Tel:
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
Immunological tolerance and immune regulation -- 1
Effector T Cell Subsets, Cytokines
B-cell mediated disease
Rheumatoid Arthritis Hayley Evans, CMCBI, King’s College London, UK
Mast Cells Y Y Y Y Y Y Y Y Y Y Y Y Y
Immunological tolerance and immune regulation -- 1
CATEGORY: PATHOGENS & DISEASE
CATEGORY: CELLS TH17 CELLS
Ulcerative colitis andTrichuris infection
Multiple Sclerosis [
Eosinophils Karen Buckland, Imperial College London, UK
Dendritic Cells: Tissue-specific
MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis Oncotarget, Vol. 6, No. 30 September 10,
Autoimmunity: Introduction
B Cells: Regulatory (Bregs)
Proposed pathogenesis of inflammatory bowel disease and target sites for pharmacological intervention. Shown are the interactions among bacterial antigens.
T cell differentiation
Flow cytometry plot gated on human CD4 T cells
Experimental Models of Inflammatory Bowel Diseases
Interferons: Type I José Ignacio Saldana, Imperial College London, UK
Intestinal nematode parasites: mechanisms of resistance
Hepatic AAV Gene Transfer and the Immune System: Friends or Foes?
Innate immunity in the large intestine
Gut-Busters: IL-17 Ain’t Afraid of No IL-23
Tumor Immunity: Exploring the Role of a Checkpoint
CD46: role in multiple sclerosis
Nat. Rev. Nephrol. doi: /nrneph
Immunological memory Topics Immune regulation  T cells
CATEGORY: PATHOGENS & DISEASE
From: monocytes, macrophages and DCs
Differentiation and Functions of CD8+ Effector T Cells
Figure 3 The T-cell cytokine tree in IBD
Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
Volume 8, Issue 3, Pages (March 1998)
INTERLEUKIN 10 (IL-10) CATEGORY: RECEPTORS & MOLECULES
Ana C. Anderson, Nicole Joller, Vijay K. Kuchroo  Immunity 
Warren Strober, Ivan J. Fuss  Gastroenterology 
B-Cell-Directed Therapy for Inflammatory Skin Diseases
Potential mechanisms of therapeutic synergy between epigenetic modulation and PD-1 pathway blockade. Potential mechanisms of therapeutic synergy between.
Host Defence Peptides B cell
Nicola L. Harris, P’ng Loke  Immunity 
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
Getting the Bugs out of the Immune System: Do Bacterial Microbiota “Fix” Intestinal T Cell Responses?  Janet Chow, Sarkis K. Mazmanian  Cell Host & Microbe 
Wenjun Ouyang, Jay K. Kolls, Yan Zheng  Immunity 
Role of the Microbiota in Immunity and Inflammation
Translating Inflammatory Bowel Disease Research into Clinical Medicine
Figure 1 New therapeutic approaches in IBD therapy based on blockade of T-cell homing and retention Figure 1 | New therapeutic approaches in IBD therapy.
Immunology Dr. Refif S. Al-Shawk
From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
B Cell Multitasking Is Required to Control Nematode Infection
Multistep Pathogenesis of Autoimmune Disease
Th1 and Th2 immune responses
Nicola L. Harris, P’ng Loke  Immunity 
Multiple Sclerosis is a neurological, immune-mediated disorder
Asthma and Allergic Inflammation
Lec.10 Immune response كلية المأمون الجامعة\قسم تقنيات التحليلات المرضية مادةالمناعة-النظري/المرحلةالثالثة م.م.رشد اياد عبدالحميد.
Inflaming the CD8+ T Cell Response
Basophils and mast cells in renal injury
Regulatory T Cells in Asthma
Alwi Shatry, Jackeline Chirinos, Michael A
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
Presentation transcript:

Regulatory T cells & parasites: therapeutic potential CATEGORY: PATHOGENS & DISEASE REGULATORY T CELLS & PARASITES: THERAPEUTIC POTENTIAL Regulatory T cells & parasites: therapeutic potential Riccardo D’Elia, Defence Science & Technology Laboratory (DSTL), Porton Down, UK Within the last few decades it has become clear that T helper (Th) cells cannot simply be divided into Th1 and Th2 cells. The re-discovery of CD4+ regulatory T cells (Tregs) (from archived suppressor T cell studies) and even more recently the discovery of Th17 cells has further extended the CD4+ Th cell family. Regulatory Cell Therapy It has been suggested that one Treg cell can influence numerous surrounding cells. With such potency, it is no surprise that these cells have been investigated as possible therapies for many diseases. Manipulation of Treg cell numbers by the addition of cytokines or parasites has been shown to be effective in controlling many aspects of inflammation. © The copyright for this work resides with the author Potential Helminth Survival strategy and Therapeutic Target. Helminths increase Treg numbers in the gut. These increases have regulatory effects on Th2 effector cells most likely by increasing production of IL-10. The Th2 response is dampened and, as a result the parasite is not expelled. Understanding the parasite- host interaction may lead to potential therapeutic candidates to treat inflammatory diseases. Parasites and Tregs Parasites have evolved in many different ways to avoid detection by their host and to manipulate their host’s immune system in order to gain an advantage and survive. The induction and/or manipulation of Tregs by parasites may be one such method to aid their survival. It may additionally be of some therapeutic value: many nematodes have been shown to stimulate an increase in Treg cells in the host post-infection in diseases such as Crohn's disease, multiple sclerosis and ulcerative colitis in which immune regulation has been disrupted. Early studies using nematodes to treat autoimmune diseases have yielded encouraging results. T.suis, a pig whipworm related to the human parasite T.trichiura, has been shown to alleviate disease symptoms in patients suffering from colitis. Removal of parasite-induced Tregs with cocktails of antibodies has been shown to affect the survival of helminths and other parasites within mouse models. When Treg cells were depleted in Litomosoides sigmodontis-infected mice using combinations of anti-CD25 and anti-CTLA4 or anti- CD25 and anti-GITR antibodies, parasite numbers were reduced. These studies suggest that the Treg cells aid parasite survival and that the parasite might have evolved the ability to induce Treg cells to do so. Conversely, other studies suggest a role of Tregs in the protection of the host against immune pathology, with anti-GITR or anti-CD25 causing mortality of mice following Trypanosoma cruzi infection. Thus Treg cells are important not only for parasite survival but also for regulation of the host inflammatory response. Indeed, it is essential for the host to find an equilibrium, which may mean that, in some cases, the parasite will survive.